William Freed-Pastor, MD, PhD, is a medical oncologist and physician-scientist at Dana-Farber Cancer Institute, specializing in gastrointestinal oncology and immuno-oncology. He is an investigator within the Division of Molecular and Cellular Oncology and the Hale Family Center for Pancreatic Cancer Research. He is an Assistant Professor of Medicine at Harvard Medical School and Associate Member at the Broad Institute. The Freed-Pastor laboratory is dissecting the mechanistic basis underlying translation of the Cancer Dark Proteome and using these insights to develop immune-based therapeutic strategies for cancer patients.
Dr. Freed-Pastor has been a Young Investigator on the Stand Up To Cancer (SU2C)-Lustgarten Foundation Pancreatic Cancer Interception Dream Team and he was awarded the SU2C Golden Arrow Early Career Scientist Award, Burroughs Wellcome Career Award for Medical Scientists, SU2C Sharp Award, ASCO Young Investigator Award, PanCAN Career Development Award, SU2C Nina Nicolai Innovation in Collaboration Award, V Foundation Translational Award, Yosemite-American Cancer Society Award, an ASCI Young Physician-Scientist Award, and an AACR NextGen Star Award. Dr. Freed-Pastor is a member of a CRUK/NCI Cancer Grand Challenges team (Team ILLUMINE) to investigate the Cancer Dark Proteome.